Global Biological Multiplex Assays Supply, Demand and Key Producers, 2026-2032
The global Biological Multiplex Assays market size is expected to reach $ 6060 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032).
The gross profit margin of major companies in the industry was approximately 45%–65%.
Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.
The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.
The gross profit margin of major companies in the industry was approximately 45%–65%.
Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.
The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.
This report is a detailed and comprehensive analysis of the world market for Biological Multiplex Assays, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Multiplex Assays that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biological Multiplex Assays market
2. What is the demand of the global Biological Multiplex Assays market?
3. What is the year over year growth of the global Biological Multiplex Assays market?
4. What is the total value of the global Biological Multiplex Assays market?
5. Who are the Major Players in the global Biological Multiplex Assays market?
6. What are the growth factors driving the market demand?
The gross profit margin of major companies in the industry was approximately 45%–65%.
Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.
The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.
The gross profit margin of major companies in the industry was approximately 45%–65%.
Biological Multiplex Assay is an analytical testing approach that simultaneously detects or quantifies multiple biological targets within a single sample. It commonly uses bead-based arrays, microarrays, flow cytometry, immunoassays, nucleic acid technologies, and related multiplex platforms to measure proteins, genes, antibodies, cytokines, or biomarkers. The technology improves sample utilization, throughput, and analytical efficiency and is widely used in life science research, clinical diagnostics, drug development, immunology, oncology, and biomarker analysis.
The industrial chain of Biological Multiplex Assay includes upstream antibodies, antigens, probes, primers, enzymes, fluorescent labels, magnetic beads, reagents, chips, and detection instruments; midstream covers assay development, reagent formulation, kit production, software analysis, validation, quality control, and testing services; downstream applications mainly include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology companies, research institutions, universities, and clinical research organizations.
Report Scope
This report studies the global Biological Multiplex Assays demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Biological Multiplex Assays, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Multiplex Assays that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Biological Multiplex Assays total market, 2021-2032, (USD Million)
- Global Biological Multiplex Assays total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Biological Multiplex Assays total market, key domestic companies, and share, (USD Million)
- Global Biological Multiplex Assays revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Biological Multiplex Assays total market by Type, CAGR, 2021-2032, (USD Million)
- Global Biological Multiplex Assays total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biological Multiplex Assays market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Biological Multiplex Assays Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Biological Multiplex Assays Market, Segmentation by Type:
- Bead-based Multiplex Assays
- Microarray-based Multiplex Assays
- Microfluidic Multiplex Assays
Global Biological Multiplex Assays Market, Segmentation by Equipment Configuration:
- Protein Multiplex Assays
- Nucleic Acid Multiplex Assays
- Cellular and Multi-analyte Assays
Global Biological Multiplex Assays Market, Segmentation by Maximum Test Voltage:
- Low-plex(≤10 Analytes)
- Medium-plex(>10–50 Analytes)
- High-plex(>50 Analytes)
Global Biological Multiplex Assays Market, Segmentation by Application:
- Disease Biomarker Profiling
- Drug Discovery and Development
- Immune Response and Pathway Analysis
- Other
Companies Profiled:
- DiaSorin S.p.A. / Luminex Corporation
- Bio-Rad Laboratories, Inc.
- Meso Scale Diagnostics, LLC
- Thermo Fisher Scientific Inc.
- Quanterix Corporation
- Olink Proteomics AB
- QIAGEN N.V.
- Standard BioTools Inc.
- Randox Laboratories Ltd.
- Revvity, Inc.
- Fujirebio Holdings, Inc.
- Sysmex Corporation
- Seegene Inc.
- AYOXXA Biosystems GmbH
- Tellgen Corporation
- Autobio Diagnostics Co., Ltd.
- Shenzhen YHLO Biotech Co., Ltd.
- Shanghai Fosun Long March Medical Science Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
Key Questions Answered
1. How big is the global Biological Multiplex Assays market?2. What is the demand of the global Biological Multiplex Assays market?
3. What is the year over year growth of the global Biological Multiplex Assays market?
4. What is the total value of the global Biological Multiplex Assays market?
5. Who are the Major Players in the global Biological Multiplex Assays market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biological Multiplex Assays Introduction
1.2 World Biological Multiplex Assays Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biological Multiplex Assays Total Market by Region (by Headquarter Location)
1.3.1 World Biological Multiplex Assays Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.3 China Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.4 Europe Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.5 Japan Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.6 South Korea Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.7 ASEAN Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.8 India Based Company Biological Multiplex Assays Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Multiplex Assays Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biological Multiplex Assays Consumption Value (2021-2032)
2.2 World Biological Multiplex Assays Consumption Value by Region
2.2.1 World Biological Multiplex Assays Consumption Value by Region (2021-2026)
2.2.2 World Biological Multiplex Assays Consumption Value Forecast by Region (2027-2032)
2.3 United States Biological Multiplex Assays Consumption Value (2021-2032)
2.4 China Biological Multiplex Assays Consumption Value (2021-2032)
2.5 Europe Biological Multiplex Assays Consumption Value (2021-2032)
2.6 Japan Biological Multiplex Assays Consumption Value (2021-2032)
2.7 South Korea Biological Multiplex Assays Consumption Value (2021-2032)
2.8 ASEAN Biological Multiplex Assays Consumption Value (2021-2032)
2.9 India Biological Multiplex Assays Consumption Value (2021-2032)
3 WORLD BIOLOGICAL MULTIPLEX ASSAYS COMPANIES COMPETITIVE ANALYSIS
3.1 World Biological Multiplex Assays Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biological Multiplex Assays Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biological Multiplex Assays in 2025
3.2.3 Global Concentration Ratios (CR8) for Biological Multiplex Assays in 2025
3.3 Biological Multiplex Assays Company Evaluation Quadrant
3.4 Biological Multiplex Assays Market: Overall Company Footprint Analysis
3.4.1 Biological Multiplex Assays Market: Region Footprint
3.4.2 Biological Multiplex Assays Market: Company Product Type Footprint
3.4.3 Biological Multiplex Assays Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biological Multiplex Assays Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biological Multiplex Assays Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biological Multiplex Assays Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biological Multiplex Assays Consumption Value Comparison
4.2.1 United States VS China: Biological Multiplex Assays Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biological Multiplex Assays Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biological Multiplex Assays Companies and Market Share, 2021-2026
4.3.1 United States Based Biological Multiplex Assays Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biological Multiplex Assays Revenue, (2021-2026)
4.4 China Based Companies Biological Multiplex Assays Revenue and Market Share, 2021-2026
4.4.1 China Based Biological Multiplex Assays Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biological Multiplex Assays Revenue, (2021-2026)
4.5 Rest of World Based Biological Multiplex Assays Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biological Multiplex Assays Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Multiplex Assays Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bead-based Multiplex Assays
5.2.2 Microarray-based Multiplex Assays
5.2.3 Microfluidic Multiplex Assays
5.3 Market Segment by Type
5.3.1 World Biological Multiplex Assays Market Size by Type (2021-2026)
5.3.2 World Biological Multiplex Assays Market Size by Type (2027-2032)
5.3.3 World Biological Multiplex Assays Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY EQUIPMENT CONFIGURATION
6.1 World Biological Multiplex Assays Market Size Overview by Equipment Configuration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Equipment Configuration
6.2.1 Protein Multiplex Assays
6.2.2 Nucleic Acid Multiplex Assays
6.2.3 Cellular and Multi-analyte Assays
6.3 Market Segment by Equipment Configuration
6.3.1 World Biological Multiplex Assays Market Size by Equipment Configuration (2021-2026)
6.3.2 World Biological Multiplex Assays Market Size by Equipment Configuration (2027-2032)
6.3.3 World Biological Multiplex Assays Market Size Market Share by Equipment Configuration (2027-2032)
7 MARKET ANALYSIS BY MAXIMUM TEST VOLTAGE
7.1 World Biological Multiplex Assays Market Size Overview by Maximum Test Voltage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Maximum Test Voltage
7.2.1 Low-plex(≤10 Analytes)
7.2.2 Medium-plex(>10–50 Analytes)
7.2.3 High-plex(>50 Analytes)
7.3 Market Segment by Maximum Test Voltage
7.3.1 World Biological Multiplex Assays Market Size by Maximum Test Voltage (2021-2026)
7.3.2 World Biological Multiplex Assays Market Size by Maximum Test Voltage (2027-2032)
7.3.3 World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biological Multiplex Assays Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Profiling
8.2.2 Drug Discovery and Development
8.2.3 Immune Response and Pathway Analysis
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Biological Multiplex Assays Market Size by Application (2021-2026)
8.3.2 World Biological Multiplex Assays Market Size by Application (2027-2032)
8.3.3 World Biological Multiplex Assays Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 DiaSorin S.p.A. / Luminex Corporation
9.1.1 DiaSorin S.p.A. / Luminex Corporation Details
9.1.2 DiaSorin S.p.A. / Luminex Corporation Major Business
9.1.3 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Services
9.1.4 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 DiaSorin S.p.A. / Luminex Corporation Recent Developments/Updates
9.1.6 DiaSorin S.p.A. / Luminex Corporation Competitive Strengths & Weaknesses
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Bio-Rad Laboratories, Inc. Details
9.2.2 Bio-Rad Laboratories, Inc. Major Business
9.2.3 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Services
9.2.4 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
9.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
9.3 Meso Scale Diagnostics, LLC
9.3.1 Meso Scale Diagnostics, LLC Details
9.3.2 Meso Scale Diagnostics, LLC Major Business
9.3.3 Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Services
9.3.4 Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Meso Scale Diagnostics, LLC Recent Developments/Updates
9.3.6 Meso Scale Diagnostics, LLC Competitive Strengths & Weaknesses
9.4 Thermo Fisher Scientific Inc.
9.4.1 Thermo Fisher Scientific Inc. Details
9.4.2 Thermo Fisher Scientific Inc. Major Business
9.4.3 Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Services
9.4.4 Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.4.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.5 Quanterix Corporation
9.5.1 Quanterix Corporation Details
9.5.2 Quanterix Corporation Major Business
9.5.3 Quanterix Corporation Biological Multiplex Assays Product and Services
9.5.4 Quanterix Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Quanterix Corporation Recent Developments/Updates
9.5.6 Quanterix Corporation Competitive Strengths & Weaknesses
9.6 Olink Proteomics AB
9.6.1 Olink Proteomics AB Details
9.6.2 Olink Proteomics AB Major Business
9.6.3 Olink Proteomics AB Biological Multiplex Assays Product and Services
9.6.4 Olink Proteomics AB Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Olink Proteomics AB Recent Developments/Updates
9.6.6 Olink Proteomics AB Competitive Strengths & Weaknesses
9.7 QIAGEN N.V.
9.7.1 QIAGEN N.V. Details
9.7.2 QIAGEN N.V. Major Business
9.7.3 QIAGEN N.V. Biological Multiplex Assays Product and Services
9.7.4 QIAGEN N.V. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 QIAGEN N.V. Recent Developments/Updates
9.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.8 Standard BioTools Inc.
9.8.1 Standard BioTools Inc. Details
9.8.2 Standard BioTools Inc. Major Business
9.8.3 Standard BioTools Inc. Biological Multiplex Assays Product and Services
9.8.4 Standard BioTools Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Standard BioTools Inc. Recent Developments/Updates
9.8.6 Standard BioTools Inc. Competitive Strengths & Weaknesses
9.9 Randox Laboratories Ltd.
9.9.1 Randox Laboratories Ltd. Details
9.9.2 Randox Laboratories Ltd. Major Business
9.9.3 Randox Laboratories Ltd. Biological Multiplex Assays Product and Services
9.9.4 Randox Laboratories Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Randox Laboratories Ltd. Recent Developments/Updates
9.9.6 Randox Laboratories Ltd. Competitive Strengths & Weaknesses
9.10 Revvity, Inc.
9.10.1 Revvity, Inc. Details
9.10.2 Revvity, Inc. Major Business
9.10.3 Revvity, Inc. Biological Multiplex Assays Product and Services
9.10.4 Revvity, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Revvity, Inc. Recent Developments/Updates
9.10.6 Revvity, Inc. Competitive Strengths & Weaknesses
9.11 Fujirebio Holdings, Inc.
9.11.1 Fujirebio Holdings, Inc. Details
9.11.2 Fujirebio Holdings, Inc. Major Business
9.11.3 Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Services
9.11.4 Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fujirebio Holdings, Inc. Recent Developments/Updates
9.11.6 Fujirebio Holdings, Inc. Competitive Strengths & Weaknesses
9.12 Sysmex Corporation
9.12.1 Sysmex Corporation Details
9.12.2 Sysmex Corporation Major Business
9.12.3 Sysmex Corporation Biological Multiplex Assays Product and Services
9.12.4 Sysmex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sysmex Corporation Recent Developments/Updates
9.12.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.13 Seegene Inc.
9.13.1 Seegene Inc. Details
9.13.2 Seegene Inc. Major Business
9.13.3 Seegene Inc. Biological Multiplex Assays Product and Services
9.13.4 Seegene Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Seegene Inc. Recent Developments/Updates
9.13.6 Seegene Inc. Competitive Strengths & Weaknesses
9.14 AYOXXA Biosystems GmbH
9.14.1 AYOXXA Biosystems GmbH Details
9.14.2 AYOXXA Biosystems GmbH Major Business
9.14.3 AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Services
9.14.4 AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 AYOXXA Biosystems GmbH Recent Developments/Updates
9.14.6 AYOXXA Biosystems GmbH Competitive Strengths & Weaknesses
9.15 Tellgen Corporation
9.15.1 Tellgen Corporation Details
9.15.2 Tellgen Corporation Major Business
9.15.3 Tellgen Corporation Biological Multiplex Assays Product and Services
9.15.4 Tellgen Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Tellgen Corporation Recent Developments/Updates
9.15.6 Tellgen Corporation Competitive Strengths & Weaknesses
9.16 Autobio Diagnostics Co., Ltd.
9.16.1 Autobio Diagnostics Co., Ltd. Details
9.16.2 Autobio Diagnostics Co., Ltd. Major Business
9.16.3 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Services
9.16.4 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Autobio Diagnostics Co., Ltd. Recent Developments/Updates
9.16.6 Autobio Diagnostics Co., Ltd. Competitive Strengths & Weaknesses
9.17 Shenzhen YHLO Biotech Co., Ltd.
9.17.1 Shenzhen YHLO Biotech Co., Ltd. Details
9.17.2 Shenzhen YHLO Biotech Co., Ltd. Major Business
9.17.3 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Services
9.17.4 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shenzhen YHLO Biotech Co., Ltd. Recent Developments/Updates
9.17.6 Shenzhen YHLO Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.18 Shanghai Fosun Long March Medical Science Co., Ltd.
9.18.1 Shanghai Fosun Long March Medical Science Co., Ltd. Details
9.18.2 Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
9.18.3 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Services
9.18.4 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments/Updates
9.18.6 Shanghai Fosun Long March Medical Science Co., Ltd. Competitive Strengths & Weaknesses
9.19 Beijing Strong Biotechnologies, Inc.
9.19.1 Beijing Strong Biotechnologies, Inc. Details
9.19.2 Beijing Strong Biotechnologies, Inc. Major Business
9.19.3 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Services
9.19.4 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Beijing Strong Biotechnologies, Inc. Recent Developments/Updates
9.19.6 Beijing Strong Biotechnologies, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biological Multiplex Assays Industry Chain
10.2 Biological Multiplex Assays Upstream Analysis
10.3 Biological Multiplex Assays Midstream Analysis
10.4 Biological Multiplex Assays Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Biological Multiplex Assays Introduction
1.2 World Biological Multiplex Assays Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biological Multiplex Assays Total Market by Region (by Headquarter Location)
1.3.1 World Biological Multiplex Assays Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.3 China Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.4 Europe Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.5 Japan Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.6 South Korea Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.7 ASEAN Based Company Biological Multiplex Assays Revenue (2021-2032)
1.3.8 India Based Company Biological Multiplex Assays Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Multiplex Assays Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biological Multiplex Assays Consumption Value (2021-2032)
2.2 World Biological Multiplex Assays Consumption Value by Region
2.2.1 World Biological Multiplex Assays Consumption Value by Region (2021-2026)
2.2.2 World Biological Multiplex Assays Consumption Value Forecast by Region (2027-2032)
2.3 United States Biological Multiplex Assays Consumption Value (2021-2032)
2.4 China Biological Multiplex Assays Consumption Value (2021-2032)
2.5 Europe Biological Multiplex Assays Consumption Value (2021-2032)
2.6 Japan Biological Multiplex Assays Consumption Value (2021-2032)
2.7 South Korea Biological Multiplex Assays Consumption Value (2021-2032)
2.8 ASEAN Biological Multiplex Assays Consumption Value (2021-2032)
2.9 India Biological Multiplex Assays Consumption Value (2021-2032)
3 WORLD BIOLOGICAL MULTIPLEX ASSAYS COMPANIES COMPETITIVE ANALYSIS
3.1 World Biological Multiplex Assays Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biological Multiplex Assays Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biological Multiplex Assays in 2025
3.2.3 Global Concentration Ratios (CR8) for Biological Multiplex Assays in 2025
3.3 Biological Multiplex Assays Company Evaluation Quadrant
3.4 Biological Multiplex Assays Market: Overall Company Footprint Analysis
3.4.1 Biological Multiplex Assays Market: Region Footprint
3.4.2 Biological Multiplex Assays Market: Company Product Type Footprint
3.4.3 Biological Multiplex Assays Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biological Multiplex Assays Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biological Multiplex Assays Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biological Multiplex Assays Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biological Multiplex Assays Consumption Value Comparison
4.2.1 United States VS China: Biological Multiplex Assays Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biological Multiplex Assays Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biological Multiplex Assays Companies and Market Share, 2021-2026
4.3.1 United States Based Biological Multiplex Assays Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biological Multiplex Assays Revenue, (2021-2026)
4.4 China Based Companies Biological Multiplex Assays Revenue and Market Share, 2021-2026
4.4.1 China Based Biological Multiplex Assays Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biological Multiplex Assays Revenue, (2021-2026)
4.5 Rest of World Based Biological Multiplex Assays Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biological Multiplex Assays Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Multiplex Assays Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Bead-based Multiplex Assays
5.2.2 Microarray-based Multiplex Assays
5.2.3 Microfluidic Multiplex Assays
5.3 Market Segment by Type
5.3.1 World Biological Multiplex Assays Market Size by Type (2021-2026)
5.3.2 World Biological Multiplex Assays Market Size by Type (2027-2032)
5.3.3 World Biological Multiplex Assays Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY EQUIPMENT CONFIGURATION
6.1 World Biological Multiplex Assays Market Size Overview by Equipment Configuration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Equipment Configuration
6.2.1 Protein Multiplex Assays
6.2.2 Nucleic Acid Multiplex Assays
6.2.3 Cellular and Multi-analyte Assays
6.3 Market Segment by Equipment Configuration
6.3.1 World Biological Multiplex Assays Market Size by Equipment Configuration (2021-2026)
6.3.2 World Biological Multiplex Assays Market Size by Equipment Configuration (2027-2032)
6.3.3 World Biological Multiplex Assays Market Size Market Share by Equipment Configuration (2027-2032)
7 MARKET ANALYSIS BY MAXIMUM TEST VOLTAGE
7.1 World Biological Multiplex Assays Market Size Overview by Maximum Test Voltage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Maximum Test Voltage
7.2.1 Low-plex(≤10 Analytes)
7.2.2 Medium-plex(>10–50 Analytes)
7.2.3 High-plex(>50 Analytes)
7.3 Market Segment by Maximum Test Voltage
7.3.1 World Biological Multiplex Assays Market Size by Maximum Test Voltage (2021-2026)
7.3.2 World Biological Multiplex Assays Market Size by Maximum Test Voltage (2027-2032)
7.3.3 World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biological Multiplex Assays Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Disease Biomarker Profiling
8.2.2 Drug Discovery and Development
8.2.3 Immune Response and Pathway Analysis
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Biological Multiplex Assays Market Size by Application (2021-2026)
8.3.2 World Biological Multiplex Assays Market Size by Application (2027-2032)
8.3.3 World Biological Multiplex Assays Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 DiaSorin S.p.A. / Luminex Corporation
9.1.1 DiaSorin S.p.A. / Luminex Corporation Details
9.1.2 DiaSorin S.p.A. / Luminex Corporation Major Business
9.1.3 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Services
9.1.4 DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 DiaSorin S.p.A. / Luminex Corporation Recent Developments/Updates
9.1.6 DiaSorin S.p.A. / Luminex Corporation Competitive Strengths & Weaknesses
9.2 Bio-Rad Laboratories, Inc.
9.2.1 Bio-Rad Laboratories, Inc. Details
9.2.2 Bio-Rad Laboratories, Inc. Major Business
9.2.3 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Services
9.2.4 Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates
9.2.6 Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
9.3 Meso Scale Diagnostics, LLC
9.3.1 Meso Scale Diagnostics, LLC Details
9.3.2 Meso Scale Diagnostics, LLC Major Business
9.3.3 Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Services
9.3.4 Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Meso Scale Diagnostics, LLC Recent Developments/Updates
9.3.6 Meso Scale Diagnostics, LLC Competitive Strengths & Weaknesses
9.4 Thermo Fisher Scientific Inc.
9.4.1 Thermo Fisher Scientific Inc. Details
9.4.2 Thermo Fisher Scientific Inc. Major Business
9.4.3 Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Services
9.4.4 Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.4.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.5 Quanterix Corporation
9.5.1 Quanterix Corporation Details
9.5.2 Quanterix Corporation Major Business
9.5.3 Quanterix Corporation Biological Multiplex Assays Product and Services
9.5.4 Quanterix Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Quanterix Corporation Recent Developments/Updates
9.5.6 Quanterix Corporation Competitive Strengths & Weaknesses
9.6 Olink Proteomics AB
9.6.1 Olink Proteomics AB Details
9.6.2 Olink Proteomics AB Major Business
9.6.3 Olink Proteomics AB Biological Multiplex Assays Product and Services
9.6.4 Olink Proteomics AB Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Olink Proteomics AB Recent Developments/Updates
9.6.6 Olink Proteomics AB Competitive Strengths & Weaknesses
9.7 QIAGEN N.V.
9.7.1 QIAGEN N.V. Details
9.7.2 QIAGEN N.V. Major Business
9.7.3 QIAGEN N.V. Biological Multiplex Assays Product and Services
9.7.4 QIAGEN N.V. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 QIAGEN N.V. Recent Developments/Updates
9.7.6 QIAGEN N.V. Competitive Strengths & Weaknesses
9.8 Standard BioTools Inc.
9.8.1 Standard BioTools Inc. Details
9.8.2 Standard BioTools Inc. Major Business
9.8.3 Standard BioTools Inc. Biological Multiplex Assays Product and Services
9.8.4 Standard BioTools Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Standard BioTools Inc. Recent Developments/Updates
9.8.6 Standard BioTools Inc. Competitive Strengths & Weaknesses
9.9 Randox Laboratories Ltd.
9.9.1 Randox Laboratories Ltd. Details
9.9.2 Randox Laboratories Ltd. Major Business
9.9.3 Randox Laboratories Ltd. Biological Multiplex Assays Product and Services
9.9.4 Randox Laboratories Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Randox Laboratories Ltd. Recent Developments/Updates
9.9.6 Randox Laboratories Ltd. Competitive Strengths & Weaknesses
9.10 Revvity, Inc.
9.10.1 Revvity, Inc. Details
9.10.2 Revvity, Inc. Major Business
9.10.3 Revvity, Inc. Biological Multiplex Assays Product and Services
9.10.4 Revvity, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Revvity, Inc. Recent Developments/Updates
9.10.6 Revvity, Inc. Competitive Strengths & Weaknesses
9.11 Fujirebio Holdings, Inc.
9.11.1 Fujirebio Holdings, Inc. Details
9.11.2 Fujirebio Holdings, Inc. Major Business
9.11.3 Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Services
9.11.4 Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fujirebio Holdings, Inc. Recent Developments/Updates
9.11.6 Fujirebio Holdings, Inc. Competitive Strengths & Weaknesses
9.12 Sysmex Corporation
9.12.1 Sysmex Corporation Details
9.12.2 Sysmex Corporation Major Business
9.12.3 Sysmex Corporation Biological Multiplex Assays Product and Services
9.12.4 Sysmex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Sysmex Corporation Recent Developments/Updates
9.12.6 Sysmex Corporation Competitive Strengths & Weaknesses
9.13 Seegene Inc.
9.13.1 Seegene Inc. Details
9.13.2 Seegene Inc. Major Business
9.13.3 Seegene Inc. Biological Multiplex Assays Product and Services
9.13.4 Seegene Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Seegene Inc. Recent Developments/Updates
9.13.6 Seegene Inc. Competitive Strengths & Weaknesses
9.14 AYOXXA Biosystems GmbH
9.14.1 AYOXXA Biosystems GmbH Details
9.14.2 AYOXXA Biosystems GmbH Major Business
9.14.3 AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Services
9.14.4 AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 AYOXXA Biosystems GmbH Recent Developments/Updates
9.14.6 AYOXXA Biosystems GmbH Competitive Strengths & Weaknesses
9.15 Tellgen Corporation
9.15.1 Tellgen Corporation Details
9.15.2 Tellgen Corporation Major Business
9.15.3 Tellgen Corporation Biological Multiplex Assays Product and Services
9.15.4 Tellgen Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Tellgen Corporation Recent Developments/Updates
9.15.6 Tellgen Corporation Competitive Strengths & Weaknesses
9.16 Autobio Diagnostics Co., Ltd.
9.16.1 Autobio Diagnostics Co., Ltd. Details
9.16.2 Autobio Diagnostics Co., Ltd. Major Business
9.16.3 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Services
9.16.4 Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Autobio Diagnostics Co., Ltd. Recent Developments/Updates
9.16.6 Autobio Diagnostics Co., Ltd. Competitive Strengths & Weaknesses
9.17 Shenzhen YHLO Biotech Co., Ltd.
9.17.1 Shenzhen YHLO Biotech Co., Ltd. Details
9.17.2 Shenzhen YHLO Biotech Co., Ltd. Major Business
9.17.3 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Services
9.17.4 Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Shenzhen YHLO Biotech Co., Ltd. Recent Developments/Updates
9.17.6 Shenzhen YHLO Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.18 Shanghai Fosun Long March Medical Science Co., Ltd.
9.18.1 Shanghai Fosun Long March Medical Science Co., Ltd. Details
9.18.2 Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
9.18.3 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Services
9.18.4 Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments/Updates
9.18.6 Shanghai Fosun Long March Medical Science Co., Ltd. Competitive Strengths & Weaknesses
9.19 Beijing Strong Biotechnologies, Inc.
9.19.1 Beijing Strong Biotechnologies, Inc. Details
9.19.2 Beijing Strong Biotechnologies, Inc. Major Business
9.19.3 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Services
9.19.4 Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Beijing Strong Biotechnologies, Inc. Recent Developments/Updates
9.19.6 Beijing Strong Biotechnologies, Inc. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biological Multiplex Assays Industry Chain
10.2 Biological Multiplex Assays Upstream Analysis
10.3 Biological Multiplex Assays Midstream Analysis
10.4 Biological Multiplex Assays Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Biological Multiplex Assays Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biological Multiplex Assays Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biological Multiplex Assays Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biological Multiplex Assays Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biological Multiplex Assays Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biological Multiplex Assays Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biological Multiplex Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biological Multiplex Assays Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biological Multiplex Assays Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biological Multiplex Assays Players in 2025
Table 12. World Biological Multiplex Assays Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biological Multiplex Assays Company Evaluation Quadrant
Table 14. Head Office of Key Biological Multiplex Assays Players
Table 15. Biological Multiplex Assays Market: Company Product Type Footprint
Table 16. Biological Multiplex Assays Market: Company Product Application Footprint
Table 17. Biological Multiplex Assays Mergers & Acquisitions Activity
Table 18. United States VS China Biological Multiplex Assays Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biological Multiplex Assays Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biological Multiplex Assays Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biological Multiplex Assays Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 23. China Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biological Multiplex Assays Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biological Multiplex Assays Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 29. World Biological Multiplex Assays Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biological Multiplex Assays Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biological Multiplex Assays Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biological Multiplex Assays Market Size by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Table 33. World Biological Multiplex Assays Market Size Value by Equipment Configuration (2021-2026) & (USD Million)
Table 34. World Biological Multiplex Assays Market Size by Equipment Configuration (2027-2032) & (USD Million)
Table 35. World Biological Multiplex Assays Market Size by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Table 36. World Biological Multiplex Assays Market Size Value by Maximum Test Voltage (2021-2026) & (USD Million)
Table 37. World Biological Multiplex Assays Market Size by Maximum Test Voltage (2027-2032) & (USD Million)
Table 38. World Biological Multiplex Assays Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biological Multiplex Assays Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biological Multiplex Assays Market Size by Application (2027-2032) & (USD Million)
Table 41. DiaSorin S.p.A. / Luminex Corporation Basic Information, Manufacturing Base and Competitors
Table 42. DiaSorin S.p.A. / Luminex Corporation Major Business
Table 43. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Services
Table 44. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. DiaSorin S.p.A. / Luminex Corporation Recent Developments/Updates
Table 46. DiaSorin S.p.A. / Luminex Corporation Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Bio-Rad Laboratories, Inc. Major Business
Table 49. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Services
Table 50. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 52. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 53. Meso Scale Diagnostics, LLC Basic Information, Manufacturing Base and Competitors
Table 54. Meso Scale Diagnostics, LLC Major Business
Table 55. Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Services
Table 56. Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Meso Scale Diagnostics, LLC Recent Developments/Updates
Table 58. Meso Scale Diagnostics, LLC Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Thermo Fisher Scientific Inc. Major Business
Table 61. Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Services
Table 62. Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 64. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 65. Quanterix Corporation Basic Information, Manufacturing Base and Competitors
Table 66. Quanterix Corporation Major Business
Table 67. Quanterix Corporation Biological Multiplex Assays Product and Services
Table 68. Quanterix Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Quanterix Corporation Recent Developments/Updates
Table 70. Quanterix Corporation Competitive Strengths & Weaknesses
Table 71. Olink Proteomics AB Basic Information, Manufacturing Base and Competitors
Table 72. Olink Proteomics AB Major Business
Table 73. Olink Proteomics AB Biological Multiplex Assays Product and Services
Table 74. Olink Proteomics AB Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Olink Proteomics AB Recent Developments/Updates
Table 76. Olink Proteomics AB Competitive Strengths & Weaknesses
Table 77. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 78. QIAGEN N.V. Major Business
Table 79. QIAGEN N.V. Biological Multiplex Assays Product and Services
Table 80. QIAGEN N.V. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. QIAGEN N.V. Recent Developments/Updates
Table 82. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 83. Standard BioTools Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Standard BioTools Inc. Major Business
Table 85. Standard BioTools Inc. Biological Multiplex Assays Product and Services
Table 86. Standard BioTools Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Standard BioTools Inc. Recent Developments/Updates
Table 88. Standard BioTools Inc. Competitive Strengths & Weaknesses
Table 89. Randox Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table 90. Randox Laboratories Ltd. Major Business
Table 91. Randox Laboratories Ltd. Biological Multiplex Assays Product and Services
Table 92. Randox Laboratories Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Randox Laboratories Ltd. Recent Developments/Updates
Table 94. Randox Laboratories Ltd. Competitive Strengths & Weaknesses
Table 95. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Revvity, Inc. Major Business
Table 97. Revvity, Inc. Biological Multiplex Assays Product and Services
Table 98. Revvity, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Revvity, Inc. Recent Developments/Updates
Table 100. Revvity, Inc. Competitive Strengths & Weaknesses
Table 101. Fujirebio Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 102. Fujirebio Holdings, Inc. Major Business
Table 103. Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Services
Table 104. Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fujirebio Holdings, Inc. Recent Developments/Updates
Table 106. Fujirebio Holdings, Inc. Competitive Strengths & Weaknesses
Table 107. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 108. Sysmex Corporation Major Business
Table 109. Sysmex Corporation Biological Multiplex Assays Product and Services
Table 110. Sysmex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sysmex Corporation Recent Developments/Updates
Table 112. Sysmex Corporation Competitive Strengths & Weaknesses
Table 113. Seegene Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Seegene Inc. Major Business
Table 115. Seegene Inc. Biological Multiplex Assays Product and Services
Table 116. Seegene Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Seegene Inc. Recent Developments/Updates
Table 118. Seegene Inc. Competitive Strengths & Weaknesses
Table 119. AYOXXA Biosystems GmbH Basic Information, Manufacturing Base and Competitors
Table 120. AYOXXA Biosystems GmbH Major Business
Table 121. AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Services
Table 122. AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. AYOXXA Biosystems GmbH Recent Developments/Updates
Table 124. AYOXXA Biosystems GmbH Competitive Strengths & Weaknesses
Table 125. Tellgen Corporation Basic Information, Manufacturing Base and Competitors
Table 126. Tellgen Corporation Major Business
Table 127. Tellgen Corporation Biological Multiplex Assays Product and Services
Table 128. Tellgen Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Tellgen Corporation Recent Developments/Updates
Table 130. Tellgen Corporation Competitive Strengths & Weaknesses
Table 131. Autobio Diagnostics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. Autobio Diagnostics Co., Ltd. Major Business
Table 133. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Services
Table 134. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Autobio Diagnostics Co., Ltd. Recent Developments/Updates
Table 136. Autobio Diagnostics Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Shenzhen YHLO Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 138. Shenzhen YHLO Biotech Co., Ltd. Major Business
Table 139. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Services
Table 140. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shenzhen YHLO Biotech Co., Ltd. Recent Developments/Updates
Table 142. Shenzhen YHLO Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 143. Shanghai Fosun Long March Medical Science Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
Table 145. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Services
Table 146. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments/Updates
Table 148. Shanghai Fosun Long March Medical Science Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Beijing Strong Biotechnologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 150. Beijing Strong Biotechnologies, Inc. Major Business
Table 151. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Services
Table 152. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Beijing Strong Biotechnologies, Inc. Recent Developments/Updates
Table 154. Beijing Strong Biotechnologies, Inc. Competitive Strengths & Weaknesses
Table 155. Global Key Players of Biological Multiplex Assays Upstream (Raw Materials)
Table 156. Global Biological Multiplex Assays Typical Customers
Table 1. World Biological Multiplex Assays Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biological Multiplex Assays Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biological Multiplex Assays Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biological Multiplex Assays Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biological Multiplex Assays Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biological Multiplex Assays Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biological Multiplex Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biological Multiplex Assays Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biological Multiplex Assays Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biological Multiplex Assays Players in 2025
Table 12. World Biological Multiplex Assays Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biological Multiplex Assays Company Evaluation Quadrant
Table 14. Head Office of Key Biological Multiplex Assays Players
Table 15. Biological Multiplex Assays Market: Company Product Type Footprint
Table 16. Biological Multiplex Assays Market: Company Product Application Footprint
Table 17. Biological Multiplex Assays Mergers & Acquisitions Activity
Table 18. United States VS China Biological Multiplex Assays Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biological Multiplex Assays Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biological Multiplex Assays Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biological Multiplex Assays Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 23. China Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biological Multiplex Assays Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biological Multiplex Assays Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biological Multiplex Assays Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biological Multiplex Assays Revenue Market Share (2021-2026)
Table 29. World Biological Multiplex Assays Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biological Multiplex Assays Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biological Multiplex Assays Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biological Multiplex Assays Market Size by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Table 33. World Biological Multiplex Assays Market Size Value by Equipment Configuration (2021-2026) & (USD Million)
Table 34. World Biological Multiplex Assays Market Size by Equipment Configuration (2027-2032) & (USD Million)
Table 35. World Biological Multiplex Assays Market Size by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Table 36. World Biological Multiplex Assays Market Size Value by Maximum Test Voltage (2021-2026) & (USD Million)
Table 37. World Biological Multiplex Assays Market Size by Maximum Test Voltage (2027-2032) & (USD Million)
Table 38. World Biological Multiplex Assays Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biological Multiplex Assays Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biological Multiplex Assays Market Size by Application (2027-2032) & (USD Million)
Table 41. DiaSorin S.p.A. / Luminex Corporation Basic Information, Manufacturing Base and Competitors
Table 42. DiaSorin S.p.A. / Luminex Corporation Major Business
Table 43. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Product and Services
Table 44. DiaSorin S.p.A. / Luminex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. DiaSorin S.p.A. / Luminex Corporation Recent Developments/Updates
Table 46. DiaSorin S.p.A. / Luminex Corporation Competitive Strengths & Weaknesses
Table 47. Bio-Rad Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 48. Bio-Rad Laboratories, Inc. Major Business
Table 49. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Product and Services
Table 50. Bio-Rad Laboratories, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Bio-Rad Laboratories, Inc. Recent Developments/Updates
Table 52. Bio-Rad Laboratories, Inc. Competitive Strengths & Weaknesses
Table 53. Meso Scale Diagnostics, LLC Basic Information, Manufacturing Base and Competitors
Table 54. Meso Scale Diagnostics, LLC Major Business
Table 55. Meso Scale Diagnostics, LLC Biological Multiplex Assays Product and Services
Table 56. Meso Scale Diagnostics, LLC Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Meso Scale Diagnostics, LLC Recent Developments/Updates
Table 58. Meso Scale Diagnostics, LLC Competitive Strengths & Weaknesses
Table 59. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Thermo Fisher Scientific Inc. Major Business
Table 61. Thermo Fisher Scientific Inc. Biological Multiplex Assays Product and Services
Table 62. Thermo Fisher Scientific Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 64. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 65. Quanterix Corporation Basic Information, Manufacturing Base and Competitors
Table 66. Quanterix Corporation Major Business
Table 67. Quanterix Corporation Biological Multiplex Assays Product and Services
Table 68. Quanterix Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Quanterix Corporation Recent Developments/Updates
Table 70. Quanterix Corporation Competitive Strengths & Weaknesses
Table 71. Olink Proteomics AB Basic Information, Manufacturing Base and Competitors
Table 72. Olink Proteomics AB Major Business
Table 73. Olink Proteomics AB Biological Multiplex Assays Product and Services
Table 74. Olink Proteomics AB Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Olink Proteomics AB Recent Developments/Updates
Table 76. Olink Proteomics AB Competitive Strengths & Weaknesses
Table 77. QIAGEN N.V. Basic Information, Manufacturing Base and Competitors
Table 78. QIAGEN N.V. Major Business
Table 79. QIAGEN N.V. Biological Multiplex Assays Product and Services
Table 80. QIAGEN N.V. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. QIAGEN N.V. Recent Developments/Updates
Table 82. QIAGEN N.V. Competitive Strengths & Weaknesses
Table 83. Standard BioTools Inc. Basic Information, Manufacturing Base and Competitors
Table 84. Standard BioTools Inc. Major Business
Table 85. Standard BioTools Inc. Biological Multiplex Assays Product and Services
Table 86. Standard BioTools Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Standard BioTools Inc. Recent Developments/Updates
Table 88. Standard BioTools Inc. Competitive Strengths & Weaknesses
Table 89. Randox Laboratories Ltd. Basic Information, Manufacturing Base and Competitors
Table 90. Randox Laboratories Ltd. Major Business
Table 91. Randox Laboratories Ltd. Biological Multiplex Assays Product and Services
Table 92. Randox Laboratories Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Randox Laboratories Ltd. Recent Developments/Updates
Table 94. Randox Laboratories Ltd. Competitive Strengths & Weaknesses
Table 95. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Revvity, Inc. Major Business
Table 97. Revvity, Inc. Biological Multiplex Assays Product and Services
Table 98. Revvity, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Revvity, Inc. Recent Developments/Updates
Table 100. Revvity, Inc. Competitive Strengths & Weaknesses
Table 101. Fujirebio Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 102. Fujirebio Holdings, Inc. Major Business
Table 103. Fujirebio Holdings, Inc. Biological Multiplex Assays Product and Services
Table 104. Fujirebio Holdings, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fujirebio Holdings, Inc. Recent Developments/Updates
Table 106. Fujirebio Holdings, Inc. Competitive Strengths & Weaknesses
Table 107. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 108. Sysmex Corporation Major Business
Table 109. Sysmex Corporation Biological Multiplex Assays Product and Services
Table 110. Sysmex Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Sysmex Corporation Recent Developments/Updates
Table 112. Sysmex Corporation Competitive Strengths & Weaknesses
Table 113. Seegene Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Seegene Inc. Major Business
Table 115. Seegene Inc. Biological Multiplex Assays Product and Services
Table 116. Seegene Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Seegene Inc. Recent Developments/Updates
Table 118. Seegene Inc. Competitive Strengths & Weaknesses
Table 119. AYOXXA Biosystems GmbH Basic Information, Manufacturing Base and Competitors
Table 120. AYOXXA Biosystems GmbH Major Business
Table 121. AYOXXA Biosystems GmbH Biological Multiplex Assays Product and Services
Table 122. AYOXXA Biosystems GmbH Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. AYOXXA Biosystems GmbH Recent Developments/Updates
Table 124. AYOXXA Biosystems GmbH Competitive Strengths & Weaknesses
Table 125. Tellgen Corporation Basic Information, Manufacturing Base and Competitors
Table 126. Tellgen Corporation Major Business
Table 127. Tellgen Corporation Biological Multiplex Assays Product and Services
Table 128. Tellgen Corporation Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Tellgen Corporation Recent Developments/Updates
Table 130. Tellgen Corporation Competitive Strengths & Weaknesses
Table 131. Autobio Diagnostics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 132. Autobio Diagnostics Co., Ltd. Major Business
Table 133. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Product and Services
Table 134. Autobio Diagnostics Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Autobio Diagnostics Co., Ltd. Recent Developments/Updates
Table 136. Autobio Diagnostics Co., Ltd. Competitive Strengths & Weaknesses
Table 137. Shenzhen YHLO Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 138. Shenzhen YHLO Biotech Co., Ltd. Major Business
Table 139. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Product and Services
Table 140. Shenzhen YHLO Biotech Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Shenzhen YHLO Biotech Co., Ltd. Recent Developments/Updates
Table 142. Shenzhen YHLO Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 143. Shanghai Fosun Long March Medical Science Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 144. Shanghai Fosun Long March Medical Science Co., Ltd. Major Business
Table 145. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Product and Services
Table 146. Shanghai Fosun Long March Medical Science Co., Ltd. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Shanghai Fosun Long March Medical Science Co., Ltd. Recent Developments/Updates
Table 148. Shanghai Fosun Long March Medical Science Co., Ltd. Competitive Strengths & Weaknesses
Table 149. Beijing Strong Biotechnologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 150. Beijing Strong Biotechnologies, Inc. Major Business
Table 151. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Product and Services
Table 152. Beijing Strong Biotechnologies, Inc. Biological Multiplex Assays Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Beijing Strong Biotechnologies, Inc. Recent Developments/Updates
Table 154. Beijing Strong Biotechnologies, Inc. Competitive Strengths & Weaknesses
Table 155. Global Key Players of Biological Multiplex Assays Upstream (Raw Materials)
Table 156. Global Biological Multiplex Assays Typical Customers
LIST OF FIGURES
Figure 1. Biological Multiplex Assays Picture
Figure 2. World Biological Multiplex Assays Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biological Multiplex Assays Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biological Multiplex Assays Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biological Multiplex Assays Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 13. Biological Multiplex Assays Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biological Multiplex Assays Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biological Multiplex Assays by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biological Multiplex Assays Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biological Multiplex Assays Markets in 2025
Figure 27. United States VS China: Biological Multiplex Assays Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biological Multiplex Assays Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biological Multiplex Assays Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biological Multiplex Assays Market Size Market Share by Type in 2025
Figure 31. Bead-based Multiplex Assays
Figure 32. Microarray-based Multiplex Assays
Figure 33. Microfluidic Multiplex Assays
Figure 34. World Biological Multiplex Assays Market Size Market Share by Type (2021-2032)
Figure 35. World Biological Multiplex Assays Market Size by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Figure 36. World Biological Multiplex Assays Market Size Market Share by Equipment Configuration in 2025
Figure 37. Protein Multiplex Assays
Figure 38. Nucleic Acid Multiplex Assays
Figure 39. Cellular and Multi-analyte Assays
Figure 40. World Biological Multiplex Assays Market Size Market Share by Equipment Configuration (2021-2032)
Figure 41. World Biological Multiplex Assays Market Size by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Figure 42. World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage in 2025
Figure 43. Low-plex(≤10 Analytes)
Figure 44. Medium-plex(>10–50 Analytes)
Figure 45. High-plex(>50 Analytes)
Figure 46. World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage (2021-2032)
Figure 47. World Biological Multiplex Assays Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Biological Multiplex Assays Market Size Market Share by Application in 2025
Figure 49. Disease Biomarker Profiling
Figure 50. Drug Discovery and Development
Figure 51. Immune Response and Pathway Analysis
Figure 52. Other
Figure 53. World Biological Multiplex Assays Market Size Market Share by Application (2021-2032)
Figure 54. Biological Multiplex Assays Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Biological Multiplex Assays Picture
Figure 2. World Biological Multiplex Assays Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biological Multiplex Assays Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biological Multiplex Assays Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biological Multiplex Assays Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biological Multiplex Assays Revenue (2021-2032) & (USD Million)
Figure 13. Biological Multiplex Assays Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biological Multiplex Assays Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biological Multiplex Assays Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biological Multiplex Assays by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biological Multiplex Assays Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biological Multiplex Assays Markets in 2025
Figure 27. United States VS China: Biological Multiplex Assays Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biological Multiplex Assays Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biological Multiplex Assays Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biological Multiplex Assays Market Size Market Share by Type in 2025
Figure 31. Bead-based Multiplex Assays
Figure 32. Microarray-based Multiplex Assays
Figure 33. Microfluidic Multiplex Assays
Figure 34. World Biological Multiplex Assays Market Size Market Share by Type (2021-2032)
Figure 35. World Biological Multiplex Assays Market Size by Equipment Configuration, (USD Million), 2021 & 2025 & 2032
Figure 36. World Biological Multiplex Assays Market Size Market Share by Equipment Configuration in 2025
Figure 37. Protein Multiplex Assays
Figure 38. Nucleic Acid Multiplex Assays
Figure 39. Cellular and Multi-analyte Assays
Figure 40. World Biological Multiplex Assays Market Size Market Share by Equipment Configuration (2021-2032)
Figure 41. World Biological Multiplex Assays Market Size by Maximum Test Voltage, (USD Million), 2021 & 2025 & 2032
Figure 42. World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage in 2025
Figure 43. Low-plex(≤10 Analytes)
Figure 44. Medium-plex(>10–50 Analytes)
Figure 45. High-plex(>50 Analytes)
Figure 46. World Biological Multiplex Assays Market Size Market Share by Maximum Test Voltage (2021-2032)
Figure 47. World Biological Multiplex Assays Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Biological Multiplex Assays Market Size Market Share by Application in 2025
Figure 49. Disease Biomarker Profiling
Figure 50. Drug Discovery and Development
Figure 51. Immune Response and Pathway Analysis
Figure 52. Other
Figure 53. World Biological Multiplex Assays Market Size Market Share by Application (2021-2032)
Figure 54. Biological Multiplex Assays Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source